Tempest Therapeutics (TPST) Exchange Rate Effect (2018 - 2021)
Tempest Therapeutics' (TPST) quarterly Exchange Rate Effect came in at -$6000.0 in Q1 2021, up 83.78% year-over-year from -$3264.7 in Q1 2020, and down 102.71% quarter-over-quarter from $221000.0 in Q4 2020.
Powered by 
Analysis
Tempest Therapeutics (TPST) Exchange Rate Effect (2018 - 2021) Analysis & Trends
Tempest Therapeutics has disclosed Exchange Rate Effect across 4 years of filings, most recently posting -$6000.0 for Q1 2021.
- In Q1 2021, Exchange Rate Effect rose 83.78% year-over-year to -$6000.0; the TTM figure through Mar 2021 stood at $252000.0 (up 2420.0% YoY), while the FY2020 annual figure was $221000.0, up 569.7% from the prior year.
- Exchange Rate Effect came in at -$6000.0 for Q1 2021 at Tempest Therapeutics, down from $221000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $221000.0 in Q4 2020 to a low of -$48000.0 in Q3 2020.
- Average Exchange Rate Effect over 4 years is $28153.8, with a median of -$6000.0 recorded in 2021.
- The largest YoY upside for Exchange Rate Effect was 689.29% in 2020 against a maximum downside of 220.0% in 2020.
- Over 4 years, Exchange Rate Effect stood at $142000.0 in 2018, then sank by 80.28% to $28000.0 in 2019, then jumped by 689.29% to $221000.0 in 2020, then plunged by 102.71% to -$6000.0 in 2021.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$6000.0 in Q1 2021, $221000.0 in Q4 2020, and -$48000.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | -1.83 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 6,000.00 |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | -124,000.00 |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | -300,000.00 |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | -774,000.00 |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 1,000.00 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | -6,000.00 |
| Dec 31, 2020 | 221,000.00 |
| Sep 30, 2020 | -48,000.00 |
| Jun 30, 2020 | 85,000.00 |
| Mar 31, 2020 | -37,000.00 |
| Dec 31, 2019 | 28,000.00 |
| Sep 30, 2019 | 40,000.00 |
| Jun 30, 2019 | -21,000.00 |
| Mar 31, 2019 | -14,000.00 |
| Dec 31, 2018 | 142,000.00 |
| Sep 30, 2018 | -20,000.00 |
| Jun 30, 2018 | -34,000.00 |
| Mar 31, 2018 | 30,000.00 |